Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cesca Therapeutics I (KOOL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,910
  • Shares Outstanding, K 9,970
  • Annual Sales, $ 14,530 K
  • Annual Income, $ -29,100 K
  • 36-Month Beta -0.87
  • Price/Sales 2.04
  • Price/Cash Flow 13.80
  • Price/Book 0.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.77 +8.30%
on 12/28/17
3.92 -23.47%
on 01/09/18
+0.16 (+5.63%)
since 12/19/17
3-Month
2.62 +14.50%
on 12/14/17
4.14 -27.54%
on 11/21/17
-0.90 (-23.08%)
since 10/19/17
52-Week
2.62 +14.50%
on 12/14/17
6.44 -53.42%
on 10/03/17
-0.03 (-0.99%)
since 01/19/17

Most Recent Stories

More News
Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018

Cesca Therapeutics Inc. ("Cesca") (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Chris Xu, Ph.D., chief executive officer,...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics Inc. to Participate in the LD Micro 10th Annual Main Event on Thursday, December 7, 2017

Cesca Therapeutics Inc. ("Cesca") (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Joe Balagot, senior vice president...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock

Cesca Therapeutics Inc. ("Cesca") (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has priced a best efforts registered...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock

Cesca Therapeutics Inc. ("Cesca") (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced a proposed registered public offering of...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing today announced that on November 21, 2017, the U.S. Patent and Trademark Office (USPTO) awarded the company a new U.S...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced financial and operating results for the three months...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 14, 2017 / Cesca Therapeutics Inc. (NASDAQ: KOOL) will be discussing their earnings results in their Q1 Earnings Call to be held on Tuesday, November 14, 2017, at 4:30...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Philip Coehlo, chief technology officer of...

KOOL : 3.00 (+1.01%)
Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the company will release its financial results...

KOOL : 3.00 (+1.01%)
Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the U.S. Patent and Trademark Office (USPTO)...

KOOL : 3.00 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation,...

See More

Key Turning Points

2nd Resistance Point 3.05
1st Resistance Point 3.03
Last Price 3.00
1st Support Level 2.95
2nd Support Level 2.90

See More

52-Week High 6.44
Fibonacci 61.8% 4.98
Fibonacci 50% 4.53
Fibonacci 38.2% 4.08
Last Price 3.00
52-Week Low 2.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.